CUV 0.67% $14.72 clinuvel pharmaceuticals limited

Long overdue after a lost decade. I dont loose a second of sleep...

  1. 6 Posts.
    lightbulb Created with Sketch. 3
    Long overdue after a lost decade. I dont loose a second of sleep over shorters, short all you want but if management keeps door by the right things the shorters go away, management do the wrong things shorters show up. Its that simple.

    Next for CUV is to rein in that uncontrolled spending pattern that continues to erode margin/EPS combined with getting some urgency on delivering the clinical programmes
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.